Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution
ABSTRACT Purpose: To analyze the short-term clinical and topographic outcomes in patients with keratoconus after corneal collagen cross-linking treatment (CXL) with dextran-free isotonic riboflavin solution. Methods: In this retrospective case series, 26 eyes from 26 patients with keratoconus were studied. The best corrected visual acuity (BCVA) and refractive and topographic findings were analyzed at a 6-month follow-up. Results: The mean BCVA (Snellen lines) values before and 1, 3, and 6 months after CXL were 0.51 ± 0.2, 0.48 ± 0.2, 0.57 ± 0.2, and 0.64 ± 0.2, respectively, and the difference between the preoperative and 6-month values was statistically significant (p=0.006). The mean spherical equivalent refraction decreased from -5.6 ± 2.4 diopters (D) preoperatively to -5.0 ± 2.1 D, and mean simulated keratometry decreased from 48.5 ± 2.5 D to 47.8 ± 2.6 D at 6 months. (p=0.145 and p=0.001, respectively). In addition, the maximum keratometry decreased progressively and significantly from the preoperative value during follow-up (p=0.003). The central and minimal corneal thicknesses, including those of the epithelium, also decreased from 442.8 ± 25.6 µm and 430.5 ± 23.9 µm preoperatively to 420.7 ± 31.8 µm and 409.3 ± 28.7 µm at the most recent follow-up (p<0.001), respectively. No intraoperative or postoperative complications were observed. Conclusions: CXL with dextran-free isotonic riboflavin solution appears to be a safe treatment alternative for keratoconus and yields sustained short-term improvements in visual acuity, keratometric readings, and corneal thickness. However, long-term results are needed to confirm these outcomes.
Main Authors: | , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Conselho Brasileiro de Oftalmologia
2016
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492016000300147 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0004-27492016000300147 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0004-274920160003001472016-07-19Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solutionOltulu,RefikSatirtav,GunhalDonbaloglu,MeryemGunduz,Mehmet KemalKerimoglu,HurkanOkka,MehmetOzkagnici,AhmetKaraibrahimoglu,Adnan Cornea Collagen Cross-linking reagents Riboflavin/therapeutic use Ultraviolet rays Dextrans Visual acuity ABSTRACT Purpose: To analyze the short-term clinical and topographic outcomes in patients with keratoconus after corneal collagen cross-linking treatment (CXL) with dextran-free isotonic riboflavin solution. Methods: In this retrospective case series, 26 eyes from 26 patients with keratoconus were studied. The best corrected visual acuity (BCVA) and refractive and topographic findings were analyzed at a 6-month follow-up. Results: The mean BCVA (Snellen lines) values before and 1, 3, and 6 months after CXL were 0.51 ± 0.2, 0.48 ± 0.2, 0.57 ± 0.2, and 0.64 ± 0.2, respectively, and the difference between the preoperative and 6-month values was statistically significant (p=0.006). The mean spherical equivalent refraction decreased from -5.6 ± 2.4 diopters (D) preoperatively to -5.0 ± 2.1 D, and mean simulated keratometry decreased from 48.5 ± 2.5 D to 47.8 ± 2.6 D at 6 months. (p=0.145 and p=0.001, respectively). In addition, the maximum keratometry decreased progressively and significantly from the preoperative value during follow-up (p=0.003). The central and minimal corneal thicknesses, including those of the epithelium, also decreased from 442.8 ± 25.6 µm and 430.5 ± 23.9 µm preoperatively to 420.7 ± 31.8 µm and 409.3 ± 28.7 µm at the most recent follow-up (p<0.001), respectively. No intraoperative or postoperative complications were observed. Conclusions: CXL with dextran-free isotonic riboflavin solution appears to be a safe treatment alternative for keratoconus and yields sustained short-term improvements in visual acuity, keratometric readings, and corneal thickness. However, long-term results are needed to confirm these outcomes.info:eu-repo/semantics/openAccessConselho Brasileiro de OftalmologiaArquivos Brasileiros de Oftalmologia v.79 n.3 20162016-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492016000300147en10.5935/0004-2749.20160045 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Oltulu,Refik Satirtav,Gunhal Donbaloglu,Meryem Gunduz,Mehmet Kemal Kerimoglu,Hurkan Okka,Mehmet Ozkagnici,Ahmet Karaibrahimoglu,Adnan |
spellingShingle |
Oltulu,Refik Satirtav,Gunhal Donbaloglu,Meryem Gunduz,Mehmet Kemal Kerimoglu,Hurkan Okka,Mehmet Ozkagnici,Ahmet Karaibrahimoglu,Adnan Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution |
author_facet |
Oltulu,Refik Satirtav,Gunhal Donbaloglu,Meryem Gunduz,Mehmet Kemal Kerimoglu,Hurkan Okka,Mehmet Ozkagnici,Ahmet Karaibrahimoglu,Adnan |
author_sort |
Oltulu,Refik |
title |
Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution |
title_short |
Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution |
title_full |
Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution |
title_fullStr |
Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution |
title_full_unstemmed |
Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution |
title_sort |
six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution |
description |
ABSTRACT Purpose: To analyze the short-term clinical and topographic outcomes in patients with keratoconus after corneal collagen cross-linking treatment (CXL) with dextran-free isotonic riboflavin solution. Methods: In this retrospective case series, 26 eyes from 26 patients with keratoconus were studied. The best corrected visual acuity (BCVA) and refractive and topographic findings were analyzed at a 6-month follow-up. Results: The mean BCVA (Snellen lines) values before and 1, 3, and 6 months after CXL were 0.51 ± 0.2, 0.48 ± 0.2, 0.57 ± 0.2, and 0.64 ± 0.2, respectively, and the difference between the preoperative and 6-month values was statistically significant (p=0.006). The mean spherical equivalent refraction decreased from -5.6 ± 2.4 diopters (D) preoperatively to -5.0 ± 2.1 D, and mean simulated keratometry decreased from 48.5 ± 2.5 D to 47.8 ± 2.6 D at 6 months. (p=0.145 and p=0.001, respectively). In addition, the maximum keratometry decreased progressively and significantly from the preoperative value during follow-up (p=0.003). The central and minimal corneal thicknesses, including those of the epithelium, also decreased from 442.8 ± 25.6 µm and 430.5 ± 23.9 µm preoperatively to 420.7 ± 31.8 µm and 409.3 ± 28.7 µm at the most recent follow-up (p<0.001), respectively. No intraoperative or postoperative complications were observed. Conclusions: CXL with dextran-free isotonic riboflavin solution appears to be a safe treatment alternative for keratoconus and yields sustained short-term improvements in visual acuity, keratometric readings, and corneal thickness. However, long-term results are needed to confirm these outcomes. |
publisher |
Conselho Brasileiro de Oftalmologia |
publishDate |
2016 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492016000300147 |
work_keys_str_mv |
AT oltulurefik sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution AT satirtavgunhal sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution AT donbaloglumeryem sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution AT gunduzmehmetkemal sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution AT kerimogluhurkan sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution AT okkamehmet sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution AT ozkagniciahmet sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution AT karaibrahimogluadnan sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution |
_version_ |
1756373219619635200 |